Trials / Completed
CompletedNCT03393728
Heart Rate Variability and Hyperthyroidism: Evaluation of the Short-term Effects of Propanolol
Short Term Effects of Propanolol on Heart Rate Variability of Hyperthyroidism
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Yaounde Central Hospital · Other Government
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Objective: The aim of our study was to evaluate the short term effects of Propanolol on heart rate variability in patients with hyperthyroidism. Design: In ten patients newly diagnosed as having hyperthyroidism and naïve of all treatment specific for hyperthyroidism, we evaluated the short term effects of Propanolol on heart rate variability (HRV). Methods: We measured heart rate variability by power spectral analysis during 2 hours of rest and during Ewing's tests before and after the administration of Propanolol 40mg/12 hours orally for 72 hours.
Detailed description
Objective: The aim of our study was to evaluate the short term effects of Propanolol on heart rate variability in patients with hyperthyroidism. Design: In ten patients newly diagnosed as having hyperthyroidism and naïve of all treatment specific for hyperthyroidism, we evaluated the short term effects of Propanolol on heart rate variability (HRV). Methods: We measured heart rate variability by power spectral analysis during 2 hours of rest and during Ewing's tests before and after the administration of Propanolol 40mg/12 hours orally for 72 hours. Other outcomes included mean heart rate, mean R-R interval during 2-hour rest. The study questions the systematic adjunction of Propanolol early in the treatment of hyperthyroidism.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Propanolol | 72-hour propanolol before specific treatment of hyperthyroidism |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2008-12-30
- Completion
- 2009-09-30
- First posted
- 2018-01-08
- Last updated
- 2018-01-08
Source: ClinicalTrials.gov record NCT03393728. Inclusion in this directory is not an endorsement.